Patent details

EP2318419 Title: BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF

Basic Information

Publication number:
EP2318419
PCT Application Number:
US2009003602
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP097670509
PCT Publication Number:
WO2009154737
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
French Title of Invention:
COMPOSÉS DE BORATES ESTERS ET COMPOSITIONS PHARMACEUTIQUES CONTENANT DES COMPOSÉS
German Title of Invention:
BORONATESTERVERBINDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAVON
SPC Number:

Dates

Filing date:
16/06/2009
Grant date:
08/04/2015
EP Publication Date:
11/05/2011
PCT Publication Date:
23/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/05/2011
EP B1 Publication Date:
08/04/2015
EP B2 Publication Date:
30/10/2024
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/10/2024
 
 

Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome Chuo-ku, Osaka 540-8645, Japan (JP)

History of Owners

From:
18/11/2022
To:
17/02/2023

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

From:
16/06/2009
To:
18/11/2022

Name:
Millennium Pharmaceuticals Inc.
Address:
40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
13/05/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ZAWANEH, Peter, N.
Address:
United States (US)

2

Name:
TRUONG, Nobel, T.
Address:
United States (US)

3

Name:
NGUYEN, Phoung, M.
Address:
United States (US)

4

Name:
SKWIERCZYNSKI, Raymond, D.
Address:
United States (US)

5

Name:
MCCUBBIN, Quentin, J.
Address:
United States (US)

6

Name:
PALANIAPPAN, Vaithianathan
Address:
United States (US)

7

Name:
VARGA, Csanad, M.
Address:
United States (US)

8

Name:
ELLIOTT, Eric, L.
Address:
United States (US)

9

Name:
FERDOUS, Abu, J.
Address:
United States (US)

10

Name:
MAZAIK, Debra, L.
Address:
United States (US)

11

Name:
KAUFMAN, Michael, J.
Address:
United States (US)

12

Name:
KOMAR, Sonja, A.
Address:
United States (US)

Priority

1

Priority Number:
132244 P
Priority Date:
17/06/2008
Priority Country:
United States (US)

2

Priority Number:
211499 P
Priority Date:
31/03/2009
Priority Country:
United States (US)

Classification

IPC classification:
C07F 5/02; C07F 5/04; C07F 5/06; A61K 38/05; A61P 35/00; A61P 29/00; C07K 5/06; C07K 5/078;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/13
Publication date:
01/12/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202444
Publication date:
30/10/2024
Description:
Patent maintained (B2 publication)

2

Issue number:
202312
Publication date:
22/03/2023
Description:
Transfer of Rights

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000463A
Date Registered:
18/11/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/05/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
18/11/2022 Request For Change 9
18/11/2022 Outgoing Correspondence 1